Xin Lang Cai Jing·2026-01-19 01:28Group 1 - The core viewpoint of the news is that Kailaiying has shown significant trading activity and financial performance, with a notable increase in shareholder numbers and revenue growth [1][2]. Group 2 - On January 16, Kailaiying's stock rose by 0.78%, with a trading volume of 639 million yuan. The financing buy amount was 36.72 million yuan, while the financing repayment was 56.27 million yuan, resulting in a net financing outflow of 19.55 million yuan [1]. - As of January 16, the total balance of margin trading for Kailaiying was 853 million yuan, with a financing balance of 849 million yuan, accounting for 2.41% of the circulating market value, which is above the 50th percentile level over the past year [1]. - In terms of securities lending, on January 16, Kailaiying repaid 2,400 shares and sold 100 shares, with a selling amount of 10,700 yuan. The remaining securities lending volume was 45,900 shares, with a balance of 4.92 million yuan, also above the 50th percentile level over the past year [1]. Group 3 - As of September 30, Kailaiying had 60,100 shareholders, an increase of 45.37% compared to the previous period. The average circulating shares per person remained at 0 shares [2]. - For the period from January to September 2025, Kailaiying achieved operating revenue of 4.63 billion yuan, a year-on-year increase of 11.82%, and a net profit attributable to shareholders of 800 million yuan, up 12.66% year-on-year [2]. - Since its A-share listing, Kailaiying has distributed a total of 2.405 billion yuan in dividends, with 1.701 billion yuan distributed over the past three years [2]. Group 4 - As of September 30, 2025, among the top ten circulating shareholders of Kailaiying, the largest shareholder was Central European Medical Health Mixed A, holding 16.3189 million shares, an increase of 34,600 shares compared to the previous period [2]. - Hong Kong Central Clearing Limited ranked as the fourth largest circulating shareholder, holding 13.2877 million shares, an increase of 626,400 shares [2]. - The sixth largest circulating shareholder, Huabao Zhongzheng Medical ETF, held 5.6467 million shares, a decrease of 1 million shares compared to the previous period [2].